Justin Yan Chen
Chief Operating Officer at Tongjitang Chinese Medicines Co.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harry K. Genant | M | 81 |
Tongjitang Chinese Medicines Co.
 Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | 17 years |
| David Ray White | M | 69 |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | 17 years |
| Yongcun Chen | M | 59 |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | 18 years |
| Ashley M. Ammon | F | - |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | - |
| Zhi Ping Cui | M | 61 |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | 13 years |
| Christine Duan | F | - |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | - |
| Ling Qin | M | 65 |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | 18 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ji Ping Zhang | M | 56 |
University of International Business & Economics
| 7 years |
| Zhao Yang | M | 62 |
University of International Business & Economics
| 6 years |
| Wing Chung Chan | M | 49 |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | - |
| Ran Li | M | 43 |
University of Lancaster
| 4 years |
| Stephen Burton | M | - |
University of Lancaster
| 3 years |
| Li Wang | F | 53 |
University of International Business & Economics
| 4 years |
| Xue Hua Wang | M | 61 |
University of International Business & Economics
| 4 years |
| Wei Hong Xiao | M | 56 |
University of International Business & Economics
| 4 years |
| Chui Wan Sat | M | 55 |
University of Lancaster
| 2 years |
| Jian Ying Wang | F | 57 |
University of International Business & Economics
| 4 years |
| Xin Hu | M | - |
University of International Business & Economics
| 4 years |
| Charles Tan | M | 55 |
University of International Business & Economics
| 4 years |
| Ran Zhang | M | 56 |
University of International Business & Economics
| 4 years |
| Peng Wu | M | 60 |
University of International Business & Economics
| 4 years |
| Ming Hui Jia | M | 59 |
University of International Business & Economics
| 5 years |
| Yungao Gu | M | 56 |
University of International Business & Economics
| 4 years |
| Min Xie | M | 65 |
University of International Business & Economics
| 1 years |
| Steinar Kristoffersen | M | - |
University of Lancaster
| 4 years |
| Shi Han | M | 56 |
University of International Business & Economics
| 4 years |
| Pok Kam Li | M | 66 |
University of International Business & Economics
| 4 years |
| Tikhomirova Irina | F | 51 |
University of Lancaster
| 2 years |
| Xiu Ru Xie | M | 62 |
University of International Business & Economics
| 4 years |
| Li Ren Ding | M | 56 |
University of International Business & Economics
| 4 years |
| James Glenn Fairweather | M | - |
University of Lancaster
| 4 years |
| Louisa Harris | F | - |
University of Lancaster
| 3 years |
| Tim Pointer | M | - |
University of Lancaster
| 4 years |
| Claire Morris | F | - |
University of Lancaster
| 3 years |
| Sam Grey | F | - |
University of Lancaster
| 3 years |
| Eng Seng Lim | M | 44 |
University of Lancaster
| 4 years |
| Guo Yong Shen | M | 53 |
University of International Business & Economics
| 4 years |
| Guo Qiang Chen | M | 59 |
University of International Business & Economics
| 4 years |
| Hong Song De-Beer | F | - |
University of International Business & Economics
| 4 years |
| Wing Yan Yeung | F | 43 |
University of Lancaster
| 4 years |
| Kun Liu | F | 54 |
University of International Business & Economics
| 4 years |
| Wendy Hayes | F | 54 |
University of International Business & Economics
| 4 years |
| Rosnan Bin Rosli | M | 49 |
University of Lancaster
| 4 years |
| Qing Ping Xiao | M | 60 |
University of International Business & Economics
| 4 years |
| Jiong Li | M | 54 |
University of International Business & Economics
| 4 years |
| Yehong Ji | M | 59 |
University of International Business & Economics
| 4 years |
| Zhi Fang Lu | M | 70 |
University of International Business & Economics
| 8 years |
| Xiang Dong Zhu | M | 57 |
University of International Business & Economics
| 4 years |
| Ross Alexander Glasscoe-Heaps | M | 42 |
University of Lancaster
| 4 years |
| Yan Lin | M | 59 |
University of International Business & Economics
| 3 years |
| Jian Ping Ma | M | 60 |
University of International Business & Economics
| 4 years |
| Hong Wang | M | 59 |
University of International Business & Economics
| 4 years |
| Hui Li | M | 61 |
University of International Business & Economics
| 4 years |
| Mei Shuang | F | 56 |
University of Lancaster
| 2 years |
| Au Man | F | 60 |
University of International Business & Economics
| 4 years |
| Guang Zhu | M | 67 |
University of International Business & Economics
| 4 years |
| Li Xin Wang | M | 55 |
University of International Business & Economics
| 4 years |
| Hua Li | M | 58 |
University of International Business & Economics
| 4 years |
| Qian Zhao | M | 55 |
University of International Business & Economics
| 3 years |
| Zai Lang Gao | M | - |
University of International Business & Economics
| 1 years |
| Shao Lan Wang | M | 61 |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | - |
| Chun Lin Wang | M | 60 |
University of International Business & Economics
| 4 years |
| Harry Yang | M | 60 |
University of International Business & Economics
| 1 years |
| David Allen | M | - |
University of Lancaster
| 3 years |
| Martin Ji | M | - |
University of International Business & Economics
| 4 years |
| Xiao Mei Liu | F | 56 |
University of International Business & Economics
| 4 years |
| Minghui Jia | M | 62 |
University of International Business & Economics
| 4 years |
| Harold Zhi Ping Ding | M | 70 |
University of International Business & Economics
| 4 years |
| Chuan Fu Hao | M | 57 |
University of International Business & Economics
| 4 years |
| Zi Xin Shao | M | 56 |
University of International Business & Economics
| 4 years |
| Jie Yang | M | 61 |
University of International Business & Economics
| 4 years |
| Shee Kai Wong | M | 43 |
University of Lancaster
| 4 years |
| Fan Xing Kong | M | 59 |
University of International Business & Economics
| 4 years |
| Jin Huang | F | 56 |
University of International Business & Economics
| 4 years |
| Fa Song Zhang | M | 61 |
University of International Business & Economics
| 4 years |
| Tina Yao | F | - |
University of Lancaster
| 1 years |
| Johannes Jensen | M | 62 |
University of Lancaster
| 2 years |
| Chong Guang Wang | M | 58 |
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | 2 years |
| Chun Li | M | 62 |
University of International Business & Economics
| 4 years |
| Madame Yang Hong | F | 57 |
University of International Business & Economics
| 1 years |
| Yi Guan | M | 56 |
University of International Business & Economics
| 4 years |
| Ming Xian | M | 60 |
University of International Business & Economics
| 4 years |
| Khairuddin bin Mat Yusof | M | 75 |
University of Lancaster
| 1 years |
| Qing Yuan Qiu | M | - |
University of International Business & Economics
| 4 years |
| Zhong Shan Tian | M | 55 |
University of International Business & Economics
| 4 years |
| Jane Jin | F | 60 |
University of International Business & Economics
| 4 years |
| Qi Wang | M | 59 |
University of International Business & Economics
| 4 years |
| Simon Holden | M | 48 |
University of Lancaster
| 2 years |
| Liang Yin | M | 52 |
University of International Business & Economics
| 3 years |
| Lars Rinnan | M | - |
University of Lancaster
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 68 | 75.56% |
| United Kingdom | 22 | 24.44% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Justin Yan Chen
- Personal Network